Comparative Effects of BBT and Active Cycle of Breathing Technique on Dyspnea and Quality of Life in COPD

NCT ID: NCT05947253

Last Updated: 2023-07-17

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 40 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-05-15
• Study Completion Date: 2023-12-15

Brief Summary

Comparative effects of Butyeko breathing technique and Active Cycle of Breathing technique on dyspnea and quality of life in patients with chronic obstructive pulmonary disease

Detailed Description

A comparative study to determine the effects of butyeko breathing techniques and Active Cycle of Breathing technique on dyspnea and quality of life in patients with chronic obstructive pulmonary disease. As few researches on Butyeko breathing techniques are still present on COPD most of them are on asthma. The goal of the Butyeko Method is to improve breathing patterns, as indicated by achieving a higher breath hold time (control pause). Every five seconds improvement to the control pause, results in an alleviation of breathing difficulty and improved control of COPD The Butyeko method is a purported method of "retraining" the body's breathing pattern to correct for the presumed chronic hyperventilation and hypocapnea, and thereby treat or cure the body of these medical problems. Patients with chronic obstructive pulmonary disease (COPD) often suffer from expectoration. To address this problem, active cycle of breathing techniques (ACBT) can be applied in patients of COPD. In our study daily Butyeko breathing exercise and active cycle of breathing technique session of 30 to 35 minutes will be given to patients and effects of both techniques will be compared.

A randomized clinical trial will be conducted using convenient sampling or randomized sampling technique in population of chronic obstructive pulmonary disease (COPD).Total sample size will be of 40 and two Groups will be made Group A 20 participants received Buyteko breathing technique and Groups B 20 participants received Active cycle of breathing technique. Data will be collected by using Borg's dyspnea scale, St.George Respiratory questionnaire and by pulmonary function testing. Data will be collected from pulmonary ward Jinnah hospital Lahore whole study will take total duration of 10 months and data will be analyzed using latest version of SPSS-25 software.

Conditions

COPD

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Study Groups

BUTYEKO BREATHING TECHNIQUE

First Group A 20 participants received Buyteko breathing technique while will be given 5 days per week

Group Type: EXPERIMENTAL

Buyteko breathing technique

Intervention Type: OTHER

group A 20 participants received Buyteko breathing technique 2 session for 3 weeks

active cycle of breathing technique

Group B 20 participants received active cycle of breathing technique and session of 35min will be given 5 days per week

Group Type: EXPERIMENTAL

active cycle of breathing technique

Intervention Type: OTHER

Group B 20 participants received active cycle of breathing technique 2 session for 3 weeks

Interventions

Buyteko breathing technique

group A 20 participants received Buyteko breathing technique 2 session for 3 weeks

Intervention Type: OTHER

active cycle of breathing technique

Group B 20 participants received active cycle of breathing technique 2 session for 3 weeks

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Clinical diagnosis of COPD confirmed by smoking history.
• PFT showing irreversible airflow limitation.
• Patients hemodynamically stable.
• Males and females.
• Patients capable of completing IPAQ questionnaire

Exclusion Criteria

• Evidence of unstable cardiac disease, Pulmonale decompensation
• Disabling diseases which prevented participation in the exercise program, such as orthopedic inabilities or peripheral vascular disease.
• Systemic illness.
• Resting O2 saturation <90% with room air breathing and Patient with viral infection

• Minimum Eligible Age: 50 Years
• Maximum Eligible Age: 70 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Riphah International University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Sidra Faisal, MS.CPPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Pulmonary ward Jinnah hospital Lahore.

Lahore, Punjab Province, Pakistan

Site Status: RECRUITING

Countries

Pakistan

Central Contacts

Iqbal Tariq, PHD

Role: CONTACT

iqbal.tariq@riphah.edu.pk

O3338236752

Facility Contacts

Sidra Faisal, MS.CPPT

Role: primary

sidra.faisal@riphah.edu.pk

03022001847

References

Vogelmeier CF, Roman-Rodriguez M, Singh D, Han MK, Rodriguez-Roisin R, Ferguson GT. Goals of COPD treatment: Focus on symptoms and exacerbations. Respir Med. 2020 May;166:105938. doi: 10.1016/j.rmed.2020.105938. Epub 2020 Mar 21.

Reference Type: BACKGROUND

PMID: 32250871 (View on PubMed)

May SM, Li JT. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy Asthma Proc. 2015 Jan-Feb;36(1):4-10. doi: 10.2500/aap.2015.36.3812.

Reference Type: BACKGROUND

PMID: 25562549 (View on PubMed)

Halpin DM, Miravitlles M. Chronic obstructive pulmonary disease: the disease and its burden to society. Proc Am Thorac Soc. 2006 Sep;3(7):619-23. doi: 10.1513/pats.200603-093SS.

Reference Type: BACKGROUND

PMID: 16963544 (View on PubMed)

Fazleen A, Wilkinson T. Early COPD: current evidence for diagnosis and management. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620942128. doi: 10.1177/1753466620942128.

Reference Type: BACKGROUND

PMID: 32664818 (View on PubMed)

Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014 Aug 27;9:871-88. doi: 10.2147/COPD.S49621. eCollection 2014.

Reference Type: BACKGROUND

PMID: 25210449 (View on PubMed)

Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006 Feb;27(2):397-412. doi: 10.1183/09031936.06.00025805. No abstract available.

Reference Type: BACKGROUND

PMID: 16452599 (View on PubMed)

Other Identifiers

REC/RCR & AHS/22/0318

Identifier Type: -

Identifier Source: org_study_id